The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Osimertinib for patients (pts) with leptomeningeal metastases (LM) from EGFR-mutant non-small cell lung cancer (NSCLC): Updated results from the BLOOM study.
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; MSD; Novartis; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech; Yuhan
 
Byoung Chul Cho
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche; Yuhan
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche; Yuhan
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
Research Funding - AstraZeneca; Bayer; Novartis; Yuhan
 
Dong-Wan Kim
No Relationships to Disclose
 
Sang-We Kim
No Relationships to Disclose
 
Jong-Seok Lee
No Relationships to Disclose
 
Wu-Chou Su
No Relationships to Disclose
 
Tom John
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; AstraZeneca/MedImmune; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche
 
Stephen Chuan-Hao Kao
Honoraria - AstraZeneca; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche
 
Ronald Natale
Employment - AstraZeneca (I)
Consulting or Advisory Role - Lilly; Roche/Genentech
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Clovis Oncology; Five Prime Therapeutics
 
Jonathan Wade Goldman
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Lilly; Trovagene; Vortex Biosciences
Research Funding - Abbvie; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Corvus Pharmaceuticals; Genentech/Roche; Lilly; Threshold Pharmaceuticals
 
Philip Overend
Employment - AstraZeneca; GlaxoSmithKline; Merck Sharp & Dohme (I)
Stock and Other Ownership Interests - GlaxoSmithKline; GlaxoSmithKline (I)
 
Karthick Vishwanathan
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Xin Ye
Employment - AstraZeneca
 
Zhenfan Yang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Merck Sharp & Dohme